A comparison between the administration of oral prolonged-release oxycodone-naloxone and transdermal fentanyl in patients with moderate-to-severe cancer pain: a propensity score analysis

BACKGROUND: Opioids are the most important pharmacological treatment for moderate-to-severe cancer pain, but side effects limit their use. Transdermal fentanyl (TDF) and oral prolonged-release oxycodone-naloxone (OXN-PR) are effective in controlling chronic pain, with less constipation compared to o...

Descripción completa

Detalles Bibliográficos
Autores principales: Roberto, A, Greco, MT, Legramandi, L, Galli, F, Galli, M, Corli, O
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5590764/
https://www.ncbi.nlm.nih.gov/pubmed/28919810
http://dx.doi.org/10.2147/JPR.S141928

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5590764/
https://www.ncbi.nlm.nih.gov/pubmed/28919810
http://dx.doi.org/10.2147/JPR.S141928

Ejemplares similares